The hazy dawn of brachytherapy.

Radiother Oncol

Published: December 1998

The discovery of radium by Pierre and Marie Curie in December 1898 opened a new era in science and within a few years provided medicine with a new means of tumor treatment. Their personal contribution to the start and early development of clinical applications should not be overlooked. The Curies did not limit their support to providing radium sources to medical pioneers but took a deep interest in the horizons of radium therapy. Pierre was one of the first to search for and demonstrate a biological effect of radium radiation. He investigated the radioactivity of the waters of hydrotherapeutic resorts. Marie took care of the measurement of the medical sources personally, convinced that the result of the treatment depends on the precise knowledge of the amount of radium applied. Her perseverance resulted in the establishment of the Institut du Radium (1909) in which, besides the physico-chemical laboratory, a biological department was set up. The latter became the Fondation Curie (1920), a leading medical center of treatment and training, with an integrated team of physicists, radiobiologists and clinicians led by Regaud. One hundred years after the discovery of radium, patients benefit today from the extensive clinical experience that has been collected over the years and from sophisticated developments in application techniques, dosimetry and quality assurance; the professional risk has been precisely assessed and the improvements in material and procedure have enabled the medical personnel to work in hazard-free conditions. This outcome results from the continuous progress that the pioneers gave impulse to. This paper intends to recall their efforts and achievements, as well as the difficulties and the problems they encountered during the first 2 decades when the sturdy foundations of brachytherapy were built.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0167-8140(98)00137-6DOI Listing

Publication Analysis

Top Keywords

discovery radium
8
radium
7
hazy dawn
4
dawn brachytherapy
4
brachytherapy discovery
4
radium pierre
4
pierre marie
4
marie curie
4
curie december
4
december 1898
4

Similar Publications

Maud L. Menten: Pioneering Physician and Biochemist.

Cureus

August 2024

Internal Medicine, Wellstar Health System, Marietta, USA.

Article Synopsis
  • Dr. Maud Leanora Menten was a pioneering Canadian physician and biochemist who made significant contributions to various fields of biochemistry for over 40 years, particularly in cancer treatments and enzyme kinetics.
  • She was a trailblazer for women in science, being among the first in Canada to earn both an MD and a PhD, and after facing restrictions, she published around 100 research studies, notably collaborating with Dr. Leonor Michaelis on the famous Michaelis-Menten equation.
  • Although her contributions in hemoglobin research were overshadowed by Linus Pauling, her legacy gained recognition posthumously, with honors from the University of Toronto and the Canadian Medical Hall of Fame.
View Article and Find Full Text PDF

Marie Curie, a distinguished physicist and chemist, profoundly transformed the fields of radiology and medicine through her pioneering research on radioactivity. As the first woman to win a Nobel Prize and the only person to win in two different scientific fields, Physics (1903) and Chemistry (1911), Curie's achievements have left an indelible mark on medical science. This historical vignette explores her groundbreaking discoveries, including the isolation of radium and polonium, and her innovative applications of radioactivity in medicine, particularly in the treatment of cancer.

View Article and Find Full Text PDF

The Serendipity of Discovery: Life of a Geochemist.

Ann Rev Mar Sci

August 2024

School of the Earth, Ocean, and Environment, College of Arts and Sciences, University of South Carolina, Columbia, South Carolina, USA; email:

My strategy for writing this autobiography is to use examples of how working on seemingly different projects can often lead to outcomes more important than originally envisioned. Serendipity is a happy accident-specifically, the accident of discovering something useful without directly looking for it. This often occurs when two research projects converge unexpectedly.

View Article and Find Full Text PDF

Background: Cervical cancer remains a leading cause of death, particularly in developing countries. WHO screening guidelines recommend human papilloma virus (HPV) detection as a means to identify women at risk of developing cervical cancer. While HPV testing identifies those at risk, it does not specifically distinguish individuals with neoplasia.

View Article and Find Full Text PDF

Radium-223 ( Ra) is the first-in-class alpha-emitter to mediate tumor eradication, which is commonly thought to kill tumor cells by directly cleaving double-strand DNA. However, the immunogenic characteristics and cell death modalities triggered by Ra remain unclear. Here, it is reported that the Ra irradiation induces the pro-inflammatory damage-associated molecular patterns including calreticulin, HMGB1, and HSP70, hallmarks of tumor immunogenicity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!